Encompass Health Corporation於美國提供居家及急性後期醫療服務。公司總部位於阿拉巴馬州伯明翰。
財務指標
營業收入
2026-06-30
$1.59B
2026-03-31
$1.58B
2025-12-31
$1.54B
2025-09-30
$1.47B
營業支出
2026-06-30
$153M
2026-03-31
$466.9M
2025-12-31
$1.19B
2025-09-30
$449.1M
淨利潤
2026-06-30
$153.9M
2026-03-31
$194.5M
2025-12-31
$146.1M
2025-09-30
$126.5M
淨利潤率
2026-06-30
9.63%
2026-03-31
12.25%
2025-12-31
9.45%
2025-09-30
8.56%
每股收益
2026-06-30
$1.55
2026-03-31
$1.60
2025-12-31
$1.46
2025-09-30
$1.23
息稅折舊攤銷前利潤
2026-06-30
$384.8M
2026-03-31
$407.8M
2025-12-31
$374.3M
2025-09-30
$333.1M
有效稅率
2026-06-30
20.48%
2026-03-31
19.53%
2025-12-31
21.49%
2025-09-30
20.41%
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$1.59B
$1.58B
$1.54B
$1.47B
營業支出
$153M
$466.9M
$1.19B
$449.1M
淨利潤
$153.9M
$194.5M
$146.1M
$126.5M
淨利潤率
9.63%
12.25%
9.45%
8.56%
每股收益
$1.55
$1.60
$1.46
$1.23
息稅折舊攤銷前利潤
$384.8M
$407.8M
$374.3M
$333.1M
有效稅率
20.48%
19.53%
21.49%
20.41%
常見問題
EHC stock refers to the common shares of Encompass Health Corporation, a U.S.-based healthcare services company. The ticker EHC trades on the New York Stock Exchange. Encompass Health operates inpatient rehabilitation hospitals and home health and hospice agencies across the United States. Investors often follow EHC as a way to gain exposure to the post-acute care segment of the healthcare industry, which serves patients recovering from strokes, injuries, and other conditions.
Recent performance for EHC depends on current market conditions and company-specific news, so the exact price change is best checked using the latest data on this page. The stock's movement can be influenced by quarterly earnings, Medicare reimbursement updates, patient volume trends, and broader healthcare sector sentiment. For up-to-date performance figures, including daily and year-to-date changes, refer to the live quote and chart displayed above.
Evaluating EHC's valuation involves comparing its current share price to fundamental metrics such as earnings, revenue, and cash flow. Common tools include the price-to-earnings (P/E) ratio, price-to-sales, and enterprise value-to-EBITDA, ideally measured against peers in the healthcare services sector. Investors may also review growth expectations, margins, and reimbursement trends. Current valuation multiples for EHC are available on this page, so check the latest figures before drawing conclusions.
EHC shares can be traded outside regular U.S. market hours through pre-market and after-hours sessions offered by many brokers. These extended sessions typically have lower liquidity, wider spreads, and higher volatility than the standard trading day. Not all brokers support extended-hours trading for EHC, and order types may be limited. Investors should confirm their broker's rules and consider the potential for price gaps before placing orders outside regular hours.
Encompass Health has a history of paying quarterly cash dividends to shareholders. The dividend amount and yield can change over time based on the company's financial performance, cash flow, and board decisions. To confirm whether EHC currently pays a dividend and to see the latest declared amount, review the dividend section on this page. Dividend history and payment dates are also typically available through the company's investor relations materials.
Key risks for EHC include changes in Medicare and Medicaid reimbursement policies, which significantly affect revenue. The company also faces operational risks such as labor shortages, wage inflation, and regulatory compliance costs. Competition from other post-acute care providers and potential shifts in patient volumes can impact results. Additionally, broader economic downturns and interest rate changes may influence borrowing costs and stock valuation. Investors should review EHC's risk disclosures for a full picture.